0001628280-25-010908 Sample Contracts
VYNE Therapeutics Inc. Bridgewater, NJ 08807 Attention: Chief Scientific Officer With copy by email to: Iain Stuart (Iain.Stuart@VYNEtx.com) With copy to: VYNE Therapeutics Inc. Bridgewater, NJ 08807 Attention: General Counsel With copy by email to:...License Agreement • March 6th, 2025 • VYNE Therapeutics Inc. • Pharmaceutical preparations
Pursuant to the Agreement, VYNE has been granted a sublicense under certain intellectual property which was licensed to Tay by the University of Dundee (“Dundee”) pursuant to that certain licence agreement between Tay and Dundee effective as of 24 July 2020 and amended and restated on 8 October 2021 (the “Head License”). Tay and Dundee now wish to enter into an agreement for the termination of the Head License and assignment of such intellectual property from Dundee and Tay.